Key Metrics
Recent changes
- Sep 23, 2026Sep 23, 2026Raised $311M Series E at a ~$2B valuation Tech Startups
- Sep 23, 2026Sep 23, 2026First reported valuation: ~$2B Tech Startups
- Sep 23, 2026Sep 23, 2026New investor: Lux Capital Tech Startups
- Sep 23, 2026Sep 23, 2026New investor: Catalio Capital Management Tech Startups
- Sep 23, 2026Sep 23, 2026New investor: T. Rowe Price Tech Startups
Earlier changes (1)
- Sep 23, 2026Sep 23, 2026Enveda Biosciences Raises $311M Series E At $2B Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2026 | Series E | $311M | ~$2B | Tech Startups |
Investors
Latest Pulse
- Sep 24, 2026Why AI Deals Are Repricing In Months, Not YearsFour venture-backed companies repriced at two to five times their own prior valuation marks in six weeks, and only one of them trains foundation models -- evidence investors are underwriting growth speed broadly, not just an AI-label premium.→
- Sep 23, 2026AI And Biotech Funding Hit A New Pace In SeptemberThree AI-driven biotech rounds and Anthropic's own life-sciences lab landed in a single week, part of a funding pace that has already pushed 2026 startup investment past 2025's full-year total.→
- Sep 23, 2026Anthropic's Claude Discovers A Novel Enzyme SystemAnthropic's new life-sciences lab used a swarm of Claude agents to identify a previously uncharacterized enzyme system with CRISPR-like DNA repeats, the first result from a group testing whether AI can accelerate biological discovery.→
- Sep 23, 2026Basecamp Research Raises $140M Led By S32Basecamp Research raised a $140 million Series C led by Bill Maris's S32, with Nvidia and Menlo Ventures' Anthology Fund among the backers, to train a new generation of its EDEN foundation models and push AI-designed therapeutics into clinical development.→
- Sep 23, 2026Enveda Biosciences Raises $311M Series E At $2BBoulder-based Enveda Biosciences raised a $311 million Series E led by Catalio Capital Management at roughly a $2 billion valuation, funding its AI platform that mines natural compounds for new drug candidates.→
- Sep 22, 2026Firecrawl Raises $75M To Build A Data Library For AgentsFirecrawl, the open-source web-data extraction startup used by more than 1.5 million developers, raised a $75 million Series B led by Smash Capital and launched Alexandria, a unified data interface meant to feed AI agents.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Shared investors
Enveda Biosciences FAQ
What is Enveda Biosciences's valuation?
Enveda Biosciences's valuation is ~$2B (As of Sep 23, 2026, Tech Startups).
Who are Enveda Biosciences's investors?
Enveda Biosciences's investors include Catalio Capital Management, Lux Capital, T. Rowe Price (As of Sep 23, 2026).
Sources & methodologyshow
Where these figures come from
- Tech StartupsValue Add VC data2 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.